AMY MILLSAP: Open Payments
NPI 1376786566 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$765 in 28 payments from 11 companies in 2025. Trend: 2023 $1,249 · 2024 $773 · 2025 $765
Food & beverage: $680Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $196 |
| Arcutis Biotherapeutics, Inc. | 4 | $172 |
| Regeneron Healthcare Solutions, Inc. | 5 | $110 |
| ABBVIE INC. | 3 | $63 |
| UCB, Inc. | 2 | $60 |
| Amgen Inc. | 2 | $50 |
| LEO Pharma Inc. | 1 | $31 |
| Organogenesis Inc. | 1 | $26 |
| Botanix SB Inc | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: TREMFYA, Zoryve, DUPIXENT, Bimzelx, OTEZLA, SKYRIZI, ANZUPGO, NOVACHOR.
Industry payments across GA — which companies pay providers there.
